Search research articles
Contact Us
Filters
Showing results (211-220 of 222) with videos related to
Page
of 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Cell Reports
|
June 8, 2017
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
Alfonso Urbanucci, Stefan J Barfeld, Ville Kytölä, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
<i>TMPRSS2-ERG</i> confers resistance to antiandrogens: mechanism and therapeutic implications
Arunachalam Sekar, Rishita Chatterjee, Boobash Raj Selvadurai, et al.
EMBO Molecular Medicine
|
May 12, 2026
TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens
Arunachalam Sekar, Boobash Raj Selvadurai, Rishita Chatterjee, et al.
Nature Communications
|
October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
Paloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Cancer Discovery
|
November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
Navonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Dae-Hwan Kim, Duanchen Sun, William K Storck, et al.
The Journal of Clinical Investigation
|
September 17, 2024
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity
Daniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
Nature Communications
|
March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
Sylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
The Journal of Clinical Investigation
|
June 2, 2025
PROX1 is an early driver of lineage plasticity in prostate cancer
Zhi Duan, Mingchen Shi, Anbarasu Kumaraswamy, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 222) with videos related to
Sort By:
Page
of 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Cell Reports
|
June 8, 2017
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
Alfonso Urbanucci, Stefan J Barfeld, Ville Kytölä, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
<i>TMPRSS2-ERG</i> confers resistance to antiandrogens: mechanism and therapeutic implications
Arunachalam Sekar, Rishita Chatterjee, Boobash Raj Selvadurai, et al.
EMBO Molecular Medicine
|
May 12, 2026
TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens
Arunachalam Sekar, Boobash Raj Selvadurai, Rishita Chatterjee, et al.
Nature Communications
|
October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
Paloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Cancer Discovery
|
November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
Navonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Dae-Hwan Kim, Duanchen Sun, William K Storck, et al.
The Journal of Clinical Investigation
|
September 17, 2024
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity
Daniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
Nature Communications
|
March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
Sylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
The Journal of Clinical Investigation
|
June 2, 2025
PROX1 is an early driver of lineage plasticity in prostate cancer
Zhi Duan, Mingchen Shi, Anbarasu Kumaraswamy, et al.
Page
of 23